A strong investment case

Our business model and strategy aim to deliver long-term growth for shareholders.

Strong demand for high-quality, affordable generics is expected to continue growing as governments manage their healthcare budgets in the face of increased pressures. We are strategically positioned to capture significant opportunities in this dynamic market environment.

Our business model

Our business model

Our diversified business model enables us to respond to the many opportunities and challenges we face, while delivering value for our patients, employees, shareholders and wider communities.
Our strategy

Our strategy

Our strategy is to deliver high-quality and affordable generic and branded generic medicines to patients.
Measuring our success

Measuring our success

We are delivering our strategy through our key strategic priorities and measuring our performance with relevant key performance indicators (KPIs).
Why invest

Why invest

With our unique and established capabilities and strategy for growth, we offer a clear proposition to investors.